Table I.
Characteristic | 5-days-on/2-days-off (n=21) | Conventional (n=21) | P-value |
---|---|---|---|
Age (years) | 67 (38-80) | 68 (46-75) | 0.9354 |
Sex | 0.0614 | ||
Male | 6 (28.6) | 12 (57.1) | |
Female | 15 (71.4) | 9 (42.9) | |
PS | 1.0000 | ||
0 | 21(100) | 21(100) | |
1 | 0 (0) | 0 (0) | |
Lymph node dissection | 0.2931 | ||
D0 | 0 (0) | 0 (0) | |
D1 | 0 (0) | 0 (0) | |
D2 | 2 (9.5) | 1 (54.8) | |
D3 | 19 (90.5) | 20 (95.2) | |
Location of cancer | 0.9588 | ||
C | 1 (4.8) | 2 (9.5) | |
A | 4 (19.0) | 4 (19.0) | |
T | 2 (9.5) | 3 (14.3) | |
D | 1 (4.8) | 1 (4.8) | |
S | 8 (38.1) | 6 (28.6) | |
RS | 2 (9.5) | 2 (9.5) | |
Ra | 3 (14.3) | 2 (9.5) | |
Rb | 0 (0) | 1 (4.8) | |
Stagea | 0.0397 | ||
IIA | 5 (23.8) | 0 (0) | |
IIB | 1 (4.8) | 0 (0) | |
IIIA | 3 (14.3) | 9 (42.9) | |
IIIB | 12 (57.1) | 11 (52.4) | |
IIIC | 0 (0) | 1 (4.8) | |
Tumor depth of invasion | 0.0727 | ||
T1 | 2 (9.5) | 4 (19.0) | |
T2 | 1 (4.8) | 5 (23.8) | |
T3 | 17 (81.0) | 8 (38.1) | |
T4 | 1 (4.8) | 4 (19.0) | |
Lymphatic invasion | 0.6200 | ||
Ly0 | 11 (52.4) | 10 (47.6) | |
Ly1 | 6 (28.6) | 6 (28.6) | |
Ly2 | 3 (14.3) | 5 (23.8) | |
Ly3 | 1 (4.8) | 0 (0) | |
Venous invasion | 0.1885 | ||
V0 | 13 (64.9) | 9 (42.9) | |
V1 | 6 (28.6) | 7 (33.3) | |
V2 | 1 (4.8) | 3 (14.3) | |
V3 | 1 (4.8) | 0 (0.0) | |
Unknown | 0 (0.0) | 2 (9.5) | |
Histological classification | 0.4283 | ||
Pap | 1 (4.8) | 0 (0.0) | |
Wel | 7 (33.3) | 10 (47.6) | |
Mod | 13 (61.9) | 11 (52.4) |
aTNM classification. Tumor depth of invasion was defined as follows: T1, tumor invades submucosa; T2, tumor invades muscularis propria; T3, tumor invades through the muscularis propria into pericolorectal tissues; T4, tumor penetrates to the surface of the visceral peritoneum or tumor directly invades or is adherent to other organs or structures. Values are expressed as the median (range) or n (%). PS, performance status; C, cecum; A, ascending colon; T, transverse colon; D, descending colon; S, sigmoid colon; Ra, upper rectum; Rb, lower rectum; Pap, papillary adenocarcinoma; Wel, well-differentiated adenocarcinoma; Mod, moderately differentiated adenocarcinoma.